Investing.com -- Macquarie is forecasting another strong year for South Korean equities, arguing that the KOSPI “should near the 6,000 mark in 2026E, driven by strong earnings growth, ample liquidity, ...

Dec 1 (Reuters) - U.S. chipmaker Marvell Technology is in advanced talks to acquire chip startup Celestial AI in a cash-and-stock deal worth multiple billions of dollars, the Information reported on ...

Bessent announced the investigation on X days after U.S. President Donald Trump called Minnesota a "hub of fraudulent money laundering activity" under Democratic Governor Tim Walz, an apparent ...

Wedbush said it expects tech stocks “to be up another 20% in 2026 as this next stage of the AI Revolution hits its stride,” supported by accelerating AI-driven deal flow at the hyperscalers and a tide ...

The 36-month facility allows BioNexus to issue and sell registered shares of its common stock to ARC at its sole discretion. As compensation for ARC’s commitment, BioNexus issued 175,000 shares of ...

Investing.com -- Silexion Therapeutics Corp (NASDAQ:SLXN) stock fell 4% Tuesday after the company announced it received formal written Scientific Advice from Germany’s Federal Institute for Drugs and ...

Investing.com -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) stock surged 10% after the precision oncology diagnostics provider secured a $500 million equity facility from ARC Group International.

Investing.com -- Eventbrite Inc (NYSE:EB) stock surged 78.6% in premarket trading Tuesday after the event management platform announced it has entered into a definitive agreement to be acquired by ...

Investing.com -- Captivision Inc (NASDAQ:CAPT) stock rose 4.6% Tuesday after the LED provider announced plans to acquire Montana Tunnels Mining, a subsidiary of Montana Goldfields, in a transformative ...

Investing.com -- European luxury stocks are entering 2026 with expectations of stabilising growth after two years of volatility, but J.P. Morgan forecasts that performance will remain sharply divided ...

The short seller alleged that A2Z Cust2Mate has "seriously misled investors with falsehoods and critical omissions about its past deals" to inflate its stock price. Pelican highlighted a 2023 ...

Investing.com -- Polyrizon Ltd. (NASDAQ:PLRZ) stock surged 80% after the biotechnology company announced the successful completion of a key manufacturing upscaling milestone for its proprietary nasal ...